- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: olaparib, durvalumab, tremelimumab
Total 1128 results
-
Sun Yat-sen UniversityRecruitingHepatocellular CarcinomaChina
-
Second Affiliated Hospital of Guangzhou Medical...RecruitingSarcoma | Cervical Cancer | Breast Cancer | Head and Neck Cancer | Gastric Cancer | Colorectal Cancer | Esophageal Cancer | Lung Cancer | Pancreas Cancer | Liver Cancer | Ovary CancerChina
-
Radboud University Medical CenterAstraZenecaCompletedHead and Neck CancerNetherlands
-
AstraZenecaActive, not recruitingNon Small Cell Lung Cancer NSCLCPoland, United States, Taiwan, Thailand, Vietnam, Korea, Republic of, United Kingdom, Brazil, Hungary, Japan, Mexico, Peru, Russian Federation, China, Germany, South Africa, Ukraine, Bulgaria, Hong Kong
-
Anwaar SaeedAstraZeneca; ExelixisActive, not recruitingHepatocellular Carcinoma | Gastric Cancer | Colorectal Cancer | Esophageal AdenocarcinomaUnited States
-
UNICANCERAstraZeneca; Intergroupe Francophone de Cancerologie Thoracique; Fondation ARCCompletedNon-small Cell Lung Cancer MetastaticFrance
-
UNICANCERAstraZenecaRecruiting
-
Asan Medical CenterActive, not recruitingMetastatic Colorectal CancerKorea, Republic of
-
University Hospital Inselspital, BerneCelgeneWithdrawnLymphoma, Large B-Cell, Diffuse
-
COMPASS PathwaysRecruiting
-
AstraZenecaCompletedGastric CancerKorea, Republic of
-
Italian Sarcoma GroupAstraZeneca; PharmaMar; Istituto Di Ricerche Farmacologiche Mario NegriCompletedSoft Tissue Sarcoma | Bone TumorItaly
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)CompletedPancreatic CancerUnited States
-
Elizabeth DudnikRecruitingPatients With Advanced Treatment Naive LCNECIsrael
-
Gustave Roussy, Cancer Campus, Grand ParisAstraZenecaRecruitingEarly Small (cT1N0) Triple Negative Breast CancerFrance
-
University Hospital, EssenRecruiting
-
Canadian Cancer Trials GroupAstraZenecaActive, not recruitingBladder CancerCanada, Spain, United Kingdom
-
AstraZenecaCompletedUnresectable Non-small Cell Lung Cancer (NSCLC)India
-
IRCCS Policlinico S. MatteoActive, not recruitingLung Cancer | Lung Cancer Stage IIIItaly
-
Mario Negri Institute for Pharmacological ResearchCompleted
-
Northwestern UniversityNational Cancer Institute (NCI); MedImmune LLC; Avon Breast Cancer FoundationCompletedStage IV Breast Cancer | Recurrent Breast Carcinoma | Estrogen Receptor Negative | Estrogen Receptor Positive | HER2/Neu NegativeUnited States
-
AstraZenecaActive, not recruitingNon-muscle-invasive Bladder CancerFrance, Spain, Belgium, Canada, Poland, Germany, Japan, Russian Federation, United Kingdom, Austria, Australia, Netherlands
-
AstraZenecaCompletedStomach Neoplasms | Small Cell Lung Carcinoma | Ovarian Neoplasms | Fallopian Tube Neoplasms | Peritoneal Neoplasms | Triple Negative Breast Neoplasms | Esophageal Squamous Cell Carcinoma | Carcinoma, Pancreatic Ductal | Carcinoma, Squamous Cell of Head and Neck | Esophagogastric Junction NeoplasmsKorea, Republic of, Japan
-
Zhejiang UniversityNot yet recruitingHepatocellular CarcinomaChina
-
Gustave Roussy, Cancer Campus, Grand ParisAstraZenecaCompletedNon Small Cell Lung CancerFrance
-
Henan Cancer HospitalRecruitingAlotinib Plus Durvalumab-Platinum-Etoposide in First-line Treatment Extensive Small-cell Lung CancerSCLC, Extensive StageChina
-
Coordinación de Investigación en Salud, MexicoUniversity College, London; Centro de Investigacion y Estudios Avanzados del... and other collaboratorsCompleted
-
AstraZenecaEnrolling by invitationCancerUnited States, France, Italy, Spain, United Kingdom, Canada, Poland, Thailand, Vietnam, Germany, Korea, Republic of, Brazil, Hungary, India, Japan, Russian Federation, China, Malaysia, Australia, Turkey, Ukraine, Bulgaria, Taiwan, Arg... and more
-
Intergroupe Francophone de Cancerologie ThoraciqueActive, not recruitingNon-small Cell Lung Cancer Stage IVFrance
-
Vastra Gotaland RegionAstraZenecaRecruitingNSCLC, Stage IFinland, Norway, Sweden
-
AstraZenecaActive, not recruitingAdvanced or Metastatic NSCLCRussian Federation
-
AstraZenecaActive, not recruitingBiliary Tract NeoplasmsFrance, Italy, United States, Thailand, Korea, Republic of, United Kingdom, India, Japan, Poland, Russian Federation, Turkey, China, Taiwan, Hong Kong, Chile, Bulgaria, Argentina
-
AstraZenecaCompletedNon-small Cell Lung CancerItaly, Poland, France, Spain, United States, Russian Federation
-
Swiss Group for Clinical Cancer ResearchActive, not recruiting
-
MedImmune LLCCompletedSolid TumorsUnited States, Korea, Republic of, Australia
-
Memorial Sloan Kettering Cancer CenterAstraZeneca; MedImmune LLCCompletedAdvanced Colorectal CancerUnited States
-
Eli Lilly and CompanyAstraZenecaTerminated
-
Washington University School of MedicineAstraZenecaTerminatedKidney Cancer | Breast Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | Non-Small Cell Lung Cancer | Nonsmall Cell Lung Cancer | Cancer of the Ovary | Renal Cancer | Colorectal Carcinoma | Ovary Cancer | Cancer of Breast | Gastroesophageal Cancer | Cancer of the Pancreas | Cancer of the Breast | Cancer... and other conditionsUnited States
-
Singapore General HospitalCelgeneUnknown
-
National Cancer Institute (NCI)Active, not recruitingMetastatic Lung Non-Small Cell Carcinoma | Stage IV Colorectal Cancer AJCC v7 | Stage IVA Colorectal Cancer AJCC v7 | Stage IVB Colorectal Cancer AJCC v7 | Metastatic Colorectal Carcinoma | Stage IV Lung Non-Small Cell Cancer AJCC v7United States, Canada
-
National Cancer Centre, SingaporeMerck Sharp & Dohme LLC; National Medical Research Council (NMRC), SingaporeNot yet recruitingRefractory Peripheral T-Cell Lymphoma | Relapsed Peripheral T-Cell LymphomaSingapore
-
MedSIRTerminatedAdvanced Breast CancerSpain
-
AstraZenecaActive, not recruiting
-
Institut BergoniéAstraZeneca; PharmaMarCompletedSoft Tissue Sarcoma | Ovarian CarcinomaFrance
-
Mario Negri Institute for Pharmacological ResearchAstraZeneca; Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoActive, not recruitingNon-small Cell Lung Cancer Stage IIIItaly, Spain, France
-
AstraZenecaParexelRecruitingNon-Muscle- Invasive Bladder CancerUnited States
-
AstraZenecaRecruitingNon-small Cell Lung CancerSpain, Italy, France, Canada, Portugal, United States, Czechia, Germany, Sweden, Austria, Hungary
-
ETOP IBCSG Partners FoundationTakedaRecruitingNSCLC, Stage III | ALK-rearrangementFrance, Spain, Italy, Poland, United Kingdom
-
Seoul National University HospitalRecruitingBile Duct Cancer | Chemotherapy EffectKorea, Republic of
-
AstraZenecaActive, not recruitingSolid TumorsUnited States, France